Gout is a common chronic inflammatory arthritis that affects 1-5% of adults globally. Chronic kidney disease (CKD) is a common comorbidity of gout, present in 20-30% or more of patients with gout. Urate-lowering therapy (ULT) is the backbone of gout management, but some clinicians are cautious about its use among patients who also have CKD due to concerns that ULT may worsen kidney function. However, there is no clear evidence to support this idea. ...
Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
What is the association of gout with CV disease and mortality risk in patients with type 2 diabetes and can CKD modify it?
A secondary analysis of DCP trial data sought to understand the effects of thiazide diuretics on kidney outcomes.
Researchers studied the associations among patient characteristics, CKRT prescription, and survival in pediatric patients.
Researchers summarized findings on dietary interventions to reduce acid load to manage metabolic acidosis in adults with CKD.
The American Kidney Fund is providing emergency financial aid to patients impacted by the California wildfires.
The EMPA-KIDNEY trial examined the effects of SGLT2 inhibition on uric acid and gout in patients with CKD.
A study identified modifiable dialysis-related factors associated with fatigue and dialysis recovery time.
The renal effects and safety of acetazolamide in patients with type 1 diabetes was the subject of a recent study.
The International Society of Nephrology (ISN) has announced the 2025 recipients of the ISN Awards and ISN Pioneer Awards.
Researchers studied the association between chronic kidney disease and postoperative complications.
Advertisement
Expert Interviews
In Print
ASN Kidney Week 2024, the future of nephrology, the relationship between CKD and osteoarthritis, and more.
Tribute to Nicoloas Madias, amino acid infusion to reduce AKI risk, felzartamab results, and more.
Conferences
The American Society of Nephrology's annual meeting to highlight the latest scientific and medical advances in the field
ATC provides a forum for exchange of new scientific and clinical information relevant to transplantation.
The annual nephrology meeting organized by the European Renal Association
The National Kidney Foundation's premier educational event designed for the interprofessional kidney health team
Podcasts
Listen to the discussion of Chapter 16 of Dr. Burton Rose's book, focused on edematous states.
Freely Filtered looks at the landmark study of finerenone in heart failure with preserved ejection fraction (FINEARTS study).
The Filtrate rerecorded their episode on the PRAECIS trial regarding a blood test for preeclampsia due to listener feedback.
We had a great NephJC get together. We recorded the whole event and packaged it into a podcast.
Expert Columns
Sarah Tolson shares what billing departments of dialysis programs need to know about the CMS final rule for the ESRD PPS.
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
Critical Financial Shifts Ahead: How CY 2025 ESRD PPS Changes Could Impact Small Dialysis Facilities
Sarah Tolson reviews the key financial implications of the CMS proposed rule for the ESRD Prospective Payment System.
Ajay Singh pays tribute to the late nephrologist and researcher Nicolaos Madias, MD, of Tufts Medical Center.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
Knowledge Hubs
Advertisement
Advertisement
Nephrology Times Chair
Ajay K. Singh, MBBS, FRCP, MBASenior Nephrologist, Brigham and Women’s Hospital | Senior Associate Dean, Harvard Medical School
Editorial Board
Mohamed G. Atta, MD, MPHProfessor of Medicine, Johns Hopkins School of Medicine
Timothy E. Bunchman, MDProfessor and Director, Pediatric Nephrology, Transplantation, and Rheumatology, Children’s Hospital of Richmond at VCU
Suphamai Bunnapradist, MD, MSProfessor of Medicine, David Geffen School of Medicine at UCLA | Research Director, Kidney Transplant Program, UCLA
Fernando C. Fervenza, MD, PhDProfessor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
Kenneth A. Liss, DOPartner, Hypertension and Nephrology Association, Eatontown, NJ
Joel M. Topf, MD, FACPAssistant Clinical Professor of Medicine, Oakland University William Beaumont School of Medicine
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.